![Cureus | Prognostic Impact of Baseline Neutrophil-to-Eosinophil Ratio in Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab Therapy in Second or Later Lines | Article Cureus | Prognostic Impact of Baseline Neutrophil-to-Eosinophil Ratio in Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab Therapy in Second or Later Lines | Article](https://assets.cureus.com/uploads/figure/file/323136/lightbox_fb7f523082f011ec8b60b3d3abfe7040-oioioioioiouuuu.png)
Cureus | Prognostic Impact of Baseline Neutrophil-to-Eosinophil Ratio in Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab Therapy in Second or Later Lines | Article
![Frontiers | Eosinophilia and Lung Cancer: Analysis From Real-World Data and Mendelian Randomization Study Frontiers | Eosinophilia and Lung Cancer: Analysis From Real-World Data and Mendelian Randomization Study](https://www.frontiersin.org/files/Articles/830754/fmed-09-830754-HTML/image_m/fmed-09-830754-t001.jpg)
Frontiers | Eosinophilia and Lung Cancer: Analysis From Real-World Data and Mendelian Randomization Study
![Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors - ScienceDirect Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0169500220305894-ga1.jpg)
Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors - ScienceDirect
![Cureus | Elevated Eosinophil Count Following Pembrolizumab Treatment for Non-Small Cell Lung Cancer | Article Cureus | Elevated Eosinophil Count Following Pembrolizumab Treatment for Non-Small Cell Lung Cancer | Article](https://assets.cureus.com/uploads/figure/file/229994/lightbox_b2114a40d84611ebbd8cc19813b7b812-Figure-1-Eos.png)
Cureus | Elevated Eosinophil Count Following Pembrolizumab Treatment for Non-Small Cell Lung Cancer | Article
![Cancers | Free Full-Text | Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma Cancers | Free Full-Text | Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma](https://www.mdpi.com/cancers/cancers-14-02294/article_deploy/html/images/cancers-14-02294-g003.png)
Cancers | Free Full-Text | Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma
![Peripheral blood eosinophilia may be a prognostic biomarker in non-small cell lung cancer patients treated with immunotherapy - Alves - Journal of Thoracic Disease Peripheral blood eosinophilia may be a prognostic biomarker in non-small cell lung cancer patients treated with immunotherapy - Alves - Journal of Thoracic Disease](https://cdn.amegroups.cn/journals/pbpc/files/journals/2/articles/51158/public/51158-PB7-2856-R1.png/w300)
Peripheral blood eosinophilia may be a prognostic biomarker in non-small cell lung cancer patients treated with immunotherapy - Alves - Journal of Thoracic Disease
![Frontiers | Eosinophilia and Lung Cancer: Analysis From Real-World Data and Mendelian Randomization Study Frontiers | Eosinophilia and Lung Cancer: Analysis From Real-World Data and Mendelian Randomization Study](https://www.frontiersin.org/files/Articles/830754/fmed-09-830754-HTML/image_m/fmed-09-830754-t003.jpg)